ISRCTN12081042
Completed
Not Applicable
A pilot study to investigate whether patients with type 1 diabetes receiving insulin pump therapy have reduced markers of oxidative stress and cardiovascular risk compared to those on multiple daily injections
niversity of the Highlands and Islands (UK)0 sites48 target enrollmentSeptember 9, 2015
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity of the Highlands and Islands (UK)
- Enrollment
- 48
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients with type 1 diabetes
- •2\. Group A: patients not on insulin pump therapy and not on statin n\=12
- •3\. Group B: patients not on insulin pump therapy, but on statin n\=12
- •4\. Group C: patients on insulin pump therapy \> 6 months and not on a statin n\=12
- •5\. Group D: patients on insulin pump therapy \> 6 months and on a statin n\=12
Exclusion Criteria
- •1\. Type 2 diabetes
- •2\. Very poor glucose control (HbA1c \> 84 mmol/mol (10%)
- •3\. Renal impairment (eGFR \< 60ml/min/kg)
- •4\. Recently diagnosed patients (\<5 years)
- •5\. Smokers or recently stopped (\<6 months) ex\-smokers
- •6\. Chronic inflammatory disease (e.g. rheumatoid arthritis, Inflammatory bowel disease, asthma, chronic obstructive pulmonary disease)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Study to investigate the effect of AP301 on treatment of primary graft dysfunction (PGD) after primary lung transplantatioEUCTR2013-000716-21-ATApeptico Forschung und Entwicklung GmbH
Recruiting
Not Applicable
Outcome of critically ill patients with abnormal sodium levels undergoing slow low efficiency daily dialysis therapyHealth Condition 1: N179- Acute kidney failure, unspecifiedCTRI/2022/06/043320King George Medical University
Not yet recruiting
Not Applicable
The effect of Amlamax (made from Indian gooseberry) on raising good cholesterol.ACTRN12611000432910Prof Ralph Martins167
Not yet recruiting
Phase 2
Study to check the efficacy of Panchakarma procedures in the management of Multiple sclerosisHealth Condition 1: G35- Multiple sclerosisCTRI/2024/03/064562All India Institute of Ayurveda
Active, not recruiting
Not Applicable
A pilot clinical trial to evaluate the ability of pegylate r-metHg-CSF (Pegilgrastim) to accelerate haematology recovery of patients with Non-Hodgkins Lymphoma after High-dose chemiotherapy and autologous stem cell transplantation.Patients with - risk Non-Hodgkin's Lymphoma in complete or partial response who underwent autologous PBPC transplantation after high-dose chemiotherapy.MedDRA version: 6.1Level: HLTClassification code 10012819EUCTR2005-004442-14-ITIVERSITA' DEGLI STUDI DI UDINE